Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1mg DST in AVS for Primary Aldosteronism
NCT04709185Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2021
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in primary aldosteronism (PA) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Complete biochemical remission at 1 year and Complete clinical remission at 1 year. Started Jan 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT04709185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709185.